Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review
Abstract Purpose Small molecules targeting fibroblast activation protein (FAP) have emerged as a new group of tracers for positron emission tomography (PET) in 2018.While most of the existing literature has been focussed here on the application of FAP-specific PET in various kinds of cancers, some researchers have, both intentionally or unintention